Estrogen receptors: how do they signal and what are their targets N Heldring, A Pike, S Andersson, J Matthews, G Cheng, J Hartman, ... Physiological reviews 87 (3), 905-931, 2007 | 2374 | 2007 |
Chemoresistance evolution in triple-negative breast cancer delineated by single-cell sequencing C Kim, R Gao, E Sei, R Brandt, J Hartman, T Hatschek, N Crosetto, ... Cell 173 (4), 879-893. e13, 2018 | 977 | 2018 |
Estrogen receptor β inhibits 17β-estradiol-stimulated proliferation of the breast cancer cell line T47D A Ström, J Hartman, JS Foster, S Kietz, J Wimalasena, JÅ Gustafsson Proceedings of the National Academy of Sciences 101 (6), 1566-1571, 2004 | 746 | 2004 |
Clinically used breast cancer markers such as estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 are unstable throughout tumor progression LS Lindström, E Karlsson, UM Wilking, U Johansson, J Hartman, ... Journal of clinical oncology 30 (21), 2601-2608, 2012 | 629 | 2012 |
Artificial intelligence as the next step towards precision pathology B Acs, M Rantalainen, J Hartman Journal of internal medicine 288 (1), 62-81, 2020 | 392 | 2020 |
Pericyte–fibroblast transition promotes tumor growth and metastasis K Hosaka, Y Yang, T Seki, C Fischer, O Dubey, E Fredlund, J Hartman, ... Proceedings of the National Academy of Sciences 113 (38), E5618-E5627, 2016 | 344 | 2016 |
Digital image analysis in breast pathology—from image processing techniques to artificial intelligence S Robertson, H Azizpour, K Smith, J Hartman Translational Research 194, 19-35, 2018 | 343 | 2018 |
Tumor repressive functions of estrogen receptor β in SW480 colon cancer cells J Hartman, K Edvardsson, K Lindberg, C Zhao, C Williams, A Ström, ... Cancer research 69 (15), 6100-6106, 2009 | 258 | 2009 |
Estrogen receptor β inhibits angiogenesis and growth of T47D breast cancer xenografts J Hartman, K Lindberg, A Morani, J Inzunza, A Strom, JA Gustafsson Cancer research 66 (23), 11207-11213, 2006 | 256 | 2006 |
Digital image analysis outperforms manual biomarker assessment in breast cancer G Stålhammar, N Fuentes Martinez, M Lippert, NP Tobin, I Mølholm, L Kis, ... Modern Pathology 29 (4), 318-329, 2016 | 203 | 2016 |
Ribosome biogenesis during cell cycle arrest fuels EMT in development and disease V Prakash, BB Carson, JM Feenstra, RA Dass, P Sekyrova, A Hoshino, ... Nature communications 10 (1), 2110, 2019 | 195 | 2019 |
Whole-tissue biopsy phenotyping of three-dimensional tumours reveals patterns of cancer heterogeneity N Tanaka, S Kanatani, R Tomer, C Sahlgren, P Kronqvist, D Kaczynska, ... Nature Biomedical Engineering 1 (10), 796-806, 2017 | 194 | 2017 |
Estrogen receptor beta in breast cancer—diagnostic and therapeutic implications J Hartman, A Ström, JÅ Gustafsson Steroids 74 (8), 635-641, 2009 | 184 | 2009 |
CD73 immune checkpoint defines regulatory NK cells within the tumor microenvironment SY Neo, Y Yang, J Record, R Ma, X Chen, Z Chen, NP Tobin, E Blake, ... The Journal of clinical investigation 130 (3), 1185-1198, 2020 | 180 | 2020 |
High prevalence of human cytomegalovirus proteins and nucleic acids in primary breast cancer and metastatic sentinel lymph nodes C Taher, J de Boniface, AA Mohammad, P Religa, J Hartman, KC Yaiw, ... PloS one 8 (2), e56795, 2013 | 180 | 2013 |
FOXM1 is a transcriptional target of ERα and has a critical role in breast cancer endocrine sensitivity and resistance J Millour, EW Lam Breast Cancer Research 12, 1-1, 2010 | 179 | 2010 |
Pitfalls in assessing stromal tumor infiltrating lymphocytes (sTILs) in breast cancer Z Kos, E Roblin, RS Kim, S Michiels, BD Gallas, W Chen, KK van de Vijver, ... NPJ breast cancer 6 (1), 17, 2020 | 156 | 2020 |
Evolutionary history of metastatic breast cancer reveals minimal seeding from axillary lymph nodes I Ullah, GM Karthik, A Alkodsi, U Kjällquist, G Stålhammar, J Lövrot, ... The Journal of clinical investigation 128 (4), 1355-1370, 2018 | 155 | 2018 |
FoxM1 is a downstream target and marker of HER2 overexpression in breast cancer RE Francis, SS Myatt, J Krol, J Hartman, B Peck, UB McGovern, J Wang, ... International journal of oncology 35 (1), 57-68, 2009 | 152 | 2009 |
Estrogen receptors β1 and β2 have opposing roles in regulating proliferation and bone metastasis genes in the prostate cancer cell line PC3 P Dey, P Jonsson, J Hartman, C Williams, A Ström, JÅ Gustafsson Molecular endocrinology 26 (12), 1991-2003, 2012 | 147 | 2012 |